After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Discover a recent study that revealed that patients treated for prostate cancer, particularly with radiotherapy, have an ...

At the heart of this discovery lies menadione, a precursor of vitamin K that has shown remarkable ability to target and ...

Prostate cancer is one of the most common cancers among men worldwide ... diagnosed at an early stage of the disease to undergo five treatments of targeted radiation therapy. Since each radiation ...

Opinion: The tiny tattoos of radiation therapy many cancer patients receive take an emotional toll — but they're increasingly ...

THURSDAY, Nov. 7, 2024 (HealthDay News) -- Men who undergo prostate cancer treatment face a greatly increased risk of ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...